Cosmos Health Makes Initial $1M Ethereum Purchase Under Digital Asset Treasury Strategy
Cosmos Health (NASDAQ:COSM) has initiated its digital asset treasury strategy with a $1 million purchase of Ethereum (ETH). This investment is part of a larger $300 million financing facility secured with a U.S.-based institutional investor.
CEO Greg Siokas explained that this strategic move aims to diversify the company's balance sheet beyond cash holdings, citing ETH's potential appreciation and growing institutional adoption through ETFs, retirement plans, and enterprise applications.
Cosmos Health (NASDAQ:COSM) ha avviato la sua strategia di tesoreria in asset digitali con un acquisto di Ethereum (ETH) da 1 milione di dollari. Questo investimento rientra in una più ampia linea di finanziamento da 300 milioni di dollari garantita con un investitore istituzionale statunitense.
Il CEO Greg Siokas ha spiegato che questa mossa strategica mira a diversificare il bilancio oltre le riserve di liquidità, citando il potenziale apprezzamento di ETH e la crescente adozione istituzionale tramite ETF, piani pensionistici e applicazioni aziendali.
Cosmos Health (NASDAQ:COSM) ha iniciado su estrategia de tesorería en activos digitales con una compra de Ethereum (ETH) por 1 millón de dólares. Esta inversión forma parte de una línea de financiación de 300 millones de dólares acordada con un inversor institucional estadounidense.
El CEO Greg Siokas explicó que este movimiento estratégico busca diversificar el balance más allá de la liquidez en efectivo, citando el potencial de apreciación de ETH y la creciente adopción institucional a través de ETF, planes de jubilación y aplicaciones empresariales.
Cosmos Health (NASDAQ:COSM)는 이더리움(ETH) 100만 달러 매수로 디지털 자산 재무 전략을 시작했습니다. 이 투자는 미국 기반 기관 투자자와 확보한 3억 달러 금융 시설의 일부입니다.
CEO 그렉 시오카스(Greg Siokas)는 이 전략적 조치가 현금 보유를 넘어 회사의 재무구조를 다각화하려는 목적이라며, ETH의 가치 상승 잠재력과 ETF, 연금제도, 기업용 애플리케이션을 통한 기관 채택 확대를 언급했습니다.
Cosmos Health (NASDAQ:COSM) a lancé sa stratégie de trésorerie en actifs numériques avec un achat d'Ethereum (ETH) d'un million de dollars. Cet investissement s'inscrit dans le cadre d'une ligne de financement de 300 millions de dollars obtenue auprès d'un investisseur institutionnel américain.
Le PDG Greg Siokas a expliqué que cette décision stratégique vise à diversifier le bilan au-delà des liquidités, citant le potentiel d'appréciation d'ETH et l'adoption institutionnelle croissante via les ETF, les plans de retraite et les applications d'entreprise.
Cosmos Health (NASDAQ:COSM) hat seine Treasury-Strategie für digitale Assets mit einem 1-Million-Dollar-Kauf von Ethereum (ETH) eingeleitet. Diese Investition ist Teil einer größeren Finanzierungsfazilität über 300 Millionen Dollar, die mit einem US-Investor vereinbart wurde.
CEO Greg Siokas erklärte, dass dieser strategische Schritt darauf abzielt, die Bilanz über Barbestände hinaus zu diversifizieren, und verwies auf das Wertsteigerungspotenzial von ETH sowie auf die zunehmende institutionelle Akzeptanz durch ETFs, Rentenpläne und Unternehmensanwendungen.
- Access to substantial $300 million financing facility
- Strategic diversification of treasury holdings beyond cash
- Entry into growing cryptocurrency market with potential appreciation
- Exposure to cryptocurrency market volatility and risks
- Significant capital allocation to speculative digital assets
CHICAGO, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. (“Cosmos Health” or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, announced today that it has commenced purchases of Ethereum (ETH), advancing its digital asset treasury reserve strategy.
Pursuant to its financing facility of up to
Greg Siokas, CEO of Cosmos Health, stated: “We are excited to begin building our ETH treasury with this inaugural purchase. By leveraging the full potential of our facility, we aim to transform Cosmos into a significant force in the crypto space. Rather than holding only cash on our balance sheet, we are now adding an asset we believe has strong appreciation potential. ETH’s growing adoption by institutional investors, its inclusion in ETFs, the proposed expansion of cryptocurrency access in retirement plans, and the increasing enterprise use of Ethereum-based applications all reinforce our confidence in this strategic move.”
About Cosmos Health Inc.
Cosmos Health Inc. (Nasdaq:COSM), incorporated in 2009 in Nevada, is a diversified, vertically integrated global healthcare group. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life®, Mediterranation®, bio-bebe®, C-Sept® and C-Scrub®. Through its subsidiary Cana Laboratories S.A., licensed under European Good Manufacturing Practices (GMP) and certified by the European Medicines Agency (EMA), it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. Cosmos Health also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and OTC medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the UK. Furthermore, the Company has established R&D partnerships targeting major health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of novel patented nutraceuticals, specialized root extracts, proprietary complex generics, and innovative OTC products. Cosmos Health has also entered the telehealth space through the acquisition of ZipDoctor, Inc., based in Texas, USA. With a global distribution platform, the Company is currently expanding throughout Europe, Asia, and North America, and has offices and distribution centers in Thessaloniki and Athens, Greece, and in Harlow, UK. More information is available at www.cosmoshealthinc.com, www.skypremiumlife.com, www.cana.gr, www.zipdoctor.co, www.cloudscreen.gr, as well as LinkedIn and X.
Forward-Looking Statements
With the exception of the historical information contained in this news release, the matters described herein, may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements preceded by, followed by, or that otherwise, include the words "believes," "expects," "anticipates," "intends," "projects," "estimates," "plans" and similar expressions or future or conditional verbs such as "will," "should," "would," "may" and "could", are generally forward-looking in nature and not historical facts, although not all forward-looking statements include the foregoing. Such forward-looking statements include, but are not limited to, the Company’s expectation that accumulation of ETH will enhance long-term shareholder value through increasing ETH-per-share, the Company’s plans to explore additional yield-generating strategies to optimize cash flow and utility from ETH holdings, that the Facility will provide access to growth capital to support a range of strategic initiatives, including accelerated product development, advanced R&D innovation, enhanced commercial initiatives, and the Company’s planned entry into U.S. manufacturing and the anticipated use of proceeds. These statements, involve unknown risks and uncertainties that may individually or materially impact the matters discussed, herein for a variety of reasons that are outside the control of the Company, including, but not limited to, the Company's ability to raise sufficient financing to implement its business plan, and the Company's ability to successfully develop and commercialize its proprietary products and technologies. Readers are cautioned not to place undue reliance on these forward- looking statements, as actual results could differ materially from those described in the forward-looking statements contained herein. Readers are urged to read the risk factors set forth in the Company's filings with the SEC, which are available at the SEC's website (www.sec.gov). The Company disclaims any intention or obligation to update, or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Investor Relations Contact:
BDG Communications
cosm@bdgcommunications.com
FAQ
How much Ethereum did Cosmos Health (COSM) initially purchase in August 2025?
What is the total size of Cosmos Health's financing facility for digital assets?
Why is Cosmos Health (COSM) investing in Ethereum?
Who is leading Cosmos Health's cryptocurrency investment strategy?
How does the Ethereum purchase affect Cosmos Health's balance sheet?
